glp-1 agonist equivalent doses Switching between GLP‐1 receptor agonists in clinical practice: Expert consensus and practical guidance GLP-1 Medications Explained: Dosage Chart,

This is more personalized than the traditional approach of recommending a treatment to a large group of people based on broad factors

10.1016/j.smrv.2024.101761 [Google Scholar] Associated Data This section collects any data citations, data availability statements, or supplementary materials included in this article

thereafter, remain at 7mg or escalate to 14mg if needed

Each checklist item is marked as reported and the relevant page or section of the manuscript is provided

For example, a study on liraglutide found it produced greater weight loss compared to metformin, with favorable impacts on menstrual regularity

In a study of 80 obese people with type 2 diabetes receiving semaglutide and dulaglutide, a 20% reduction in the thickness of EAT was observed (62) One meta-analysis demonstrated the cardioprotective effects of GLP-1 RAs, showing reductions in blood pressure and lipid profile, with a significant increase in HDL levels (63)